ENVVENO MEDICAL CORP
NVNO · NASDAQ
Updated at 2026-10-14 09:31:18
- Today's High
- $8.65
- Today’s Low
- $7.60
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $8.80
- Previous Close
- $8.15
- Volume
- 122.87K
- Market Cap
- $5.66M
- P/E Ratio
- --
- EPS
- $-25.18
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Health Care
- Sub-industry
- MEDICAL DEVICES
- Headquarters
- 70 DOPPLER, IRVINE, CA, UNITED STATES, 92618
- Country
- US
- Listing Date
- 2018-05-31
- Fiscal Year End
- December
- Shares Outstanding
- 670K
- CIK
- 0001661053
- Website
- envveno.com
enVVeno Medical Corp (NVNO) is a pioneering medical device firm focused on revolutionizing vascular access solutions for dialysis patients with its proprietary biocompatible technology. By aiming to fulfill essential unmet needs within the dialysis sector, the company enhances the safety and effectiveness of vascular procedures, positioning itself to capture significant growth in the vascular interventions market. With a strong commitment to advanced engineering and compliance with regulatory standards, enVVeno is well-aligned with the dynamic landscape of healthcare, underscoring its mission to elevate patient outcomes in this critical area.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$3.79M
2026-03-31
$4.06M
2025-12-31
$3.89M
2025-09-30
$4.76M
Net Income
2026-06-30
-$3.6M
2026-03-31
-$3.84M
2025-12-31
-$3.73M
2025-09-30
-$4.53M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-5.37
2026-03-31
$-5.89
2025-12-31
$-5.90
2025-09-30
$-0.23
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.57M
2026-03-31
-$3.93M
2025-12-31
-$3.61M
2025-09-30
-$4.41M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $3.79M | $4.06M | $3.89M | $4.76M |
| Net Income | -$3.6M | -$3.84M | -$3.73M | -$4.53M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-5.37 | $-5.89 | $-5.90 | $-0.23 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.57M | -$3.93M | -$3.61M | -$4.41M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.